Topiramate for the treatment of juvenile myoclonic epilepsy.

@article{Sousa2005TopiramateFT,
  title={Topiramate for the treatment of juvenile myoclonic epilepsy.},
  author={Patr{\'i}cia da Silva Sousa and Gerardo Maria de Ara{\'u}jo Filho and Eliana Garz{\'o}n and Am{\'e}rico Ceiki Sakamoto and Elza M{\'a}rcia Targas Yacubian},
  journal={Arquivos de neuro-psiquiatria},
  year={2005},
  volume={63 3B},
  pages={733-7}
}
OBJECTIVE The aim of this study was to evaluate the efficacy and tolerability of topiramate (TPM) in juvenile myoclonic epilepsy (JME). METHOD We assessed seizure control and adverse effects of TPM in 22 patients (18 females) aged 13 to 53 years. Target TPM dosage was up to 200 mg/day. The patients were subdivided into 3 groups: those treated with seizure… CONTINUE READING